| PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS (NCT07761533) | Chaser Therapeutics, Inc. | 2025-09-08 |
| Odronextamab in Low Tumor Volume Advanced FL (NCT07128641) | Gottfried von Keudell, MD PhD | 2025-09-08 |
| Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 (NCT07091734) | University of Michigan | 2025-09-08 |
| A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy (NCT07305974) | Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. | 2025-09-08 |
| QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer (NCT06967103) | Henan Cancer Hospital | 2025-09-08 |
| TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease (NCT07295938) | Shanghai University of Traditional Chinese Medicine | 2025-09-08 |
| Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg (NCT05569239) | Osivax | 2025-09-08 |
| Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest (NCT07174986) | Gabriel Riva | 2025-09-08 |
| Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (NCT06814496) | University of Arizona | 2025-09-08 |
| A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma (NCT07087158) | Imbioray (Hangzhou) Biomedicine Co., Ltd. | 2025-09-08 |
| Phase 2b Controlled Study of Dosing Techniques - Part B (NCT07161011) | IVIEW Therapeutics Inc. | 2025-09-08 |
| Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT07159906) | First Affiliated Hospital of Zhejiang University | 2025-09-08 |
| Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease (NCT07148791) | Chinese PLA General Hospital | 2025-09-05 |
| AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment (NCT07158840) | Akeso | 2025-09-05 |
| A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma (NCT07099430) | Nanjing Leads Biolabs Co.,Ltd | 2025-09-05 |
| A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia (NCT07743112) | Maxinovel Pty., Ltd. | 2025-09-05 |
| A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain (NCT07029737) | AstraZeneca | 2025-09-05 |
| Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT (NCT06412510) | Case Comprehensive Cancer Center | 2025-09-05 |
| A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder (NCT07193563) | Engrail Therapeutics INC | 2025-09-05 |
| Neoadjuvant Tebentafusp for Uveal Melanoma (NCT06414590) | Thomas Jefferson University | 2025-09-05 |
| Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV (NCT07054931) | University of Oxford | 2025-09-05 |
| MDMA in Borderline Personality Disorder (NCT06683014) | Yale University | 2025-09-05 |
| Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC (NCT06726161) | RayzeBio, Inc. | 2025-09-05 |
| Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma (NCT07102901) | Jiangsu HengRui Medicine Co., Ltd. | 2025-09-05 |
| SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC (NCT07198165) | Ruijin Hospital | 2025-09-05 |
| Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial (NCT07165769) | Institute of Hematology & Blood Diseases Hospital, China | 2025-09-04 |
| A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) (NCT07128615) | AstraZeneca | 2025-09-04 |
| A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP (NCT06828991) | Danielle Wallace | 2025-09-04 |
| A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB) (NCT07137910) | Ausper Biopharma Co., Ltd. | 2025-09-04 |
| Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer (NCT07194005) | Fudan University | 2025-09-04 |
| A Study to Examine Anktiva for the Treatment of COVID-19. (NCT07123727) | ImmunityBio, Inc. | 2025-09-04 |
| A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer (NCT07082179) | Jiangsu Cancer Institute & Hospital | 2025-09-04 |
| Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer (NCT06835725) | British Columbia Cancer Agency | 2025-09-04 |
| NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer (NCT06941857) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-09-04 |
| BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis (NCT07151690) | Institute of Hematology & Blood Diseases Hospital, China | 2025-09-04 |
| Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T (NCT06784726) | University of Washington | 2025-09-04 |
| Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB) (NCT07048262) | CSL Behring | 2025-09-03 |
| A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer (NCT07137390) | M.D. Anderson Cancer Center | 2025-09-03 |
| JAK Signaling in Depression (NCT07003997) | Emory University | 2025-09-03 |
| The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) (NCT07151391) | University of Utah | 2025-09-03 |
| A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies (NCT06930651) | M.D. Anderson Cancer Center | 2025-09-03 |
| Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors (NCT07145255) | MBrace Therapeutics | 2025-09-03 |
| Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder (NCT06673394) | Tianjin Medical University General Hospital | 2025-09-03 |
| Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies (NCT07366801) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2025-09-03 |
| The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes (NCT07156773) | Guangzhou Novaken Pharm Co., Ltd. | 2025-09-03 |
| A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD (NCT07086313) | Otsuka Pharmaceutical Co., Ltd. | 2025-09-03 |
| QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer (NCT07110064) | Du Juan | 2025-09-03 |
| An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study) (NCT07161700) | Seaport Therapeutics | 2025-09-02 |
| Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection (NCT06999603) | Synairgen Research Ltd. | 2025-09-02 |
| A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression (NCT07096791) | Chengdu Kanghong Pharmaceutical Group Co., Ltd. | 2025-09-02 |
| Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime) (NCT06638151) | University of Alberta | 2025-09-02 |
| A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma (NCT07093814) | Guangzhou Virotech Pharmaceutical Co., Ltd. | 2025-09-02 |
| A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B (NCT07135349) | Shanghai Argo Biopharmaceutical Co., Ltd. | 2025-09-02 |
| KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors (NCT06747416) | Suzhou Alphamab Co., Ltd. | 2025-09-02 |
| Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms (NCT07071350) | Virginia Commonwealth University | 2025-09-02 |
| A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With Relapsed/Refractory Follicular Lymphoma That Does Not Have an "EZH2 Gain-of-function" Genetic Mutation (NCT06068881) | Epizyme, Inc. | 2025-09-02 |
| Ropiclobet for Regional Anesthesia and Post-Operative Pain Control in Upper Extremity Surgery (NCT07131657) | PHARMAFINA | 2025-09-02 |
| A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer (NCT07060365) | AstraZeneca | 2025-09-02 |
| Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients (NCT06893783) | Inkeun Park | 2025-09-02 |
| A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors (NCT07169994) | MediLink Therapeutics (Suzhou) Co., Ltd. | 2025-09-02 |
| A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NCT07023289) | AbbVie | 2025-09-02 |
| A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease (NCT06984627) | Sanofi | 2025-09-02 |
| Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS (NCT06925555) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| Methylene Blue Treatment of Chronic Hepatitis B Virus Infection (NCT06887036) | Fondazione Epatocentro Ticino | 2025-09-01 |
| Nurse-Led Elderly Sleep Intervention (NCT07251452) | University of Castilla-La Mancha | 2025-09-01 |
| 4-aminopyridine for Skin Wound Healing (NCT06333171) | John Elfar | 2025-09-01 |
| Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients (NCT07159620) | The First Affiliated Hospital of Soochow University | 2025-09-01 |
| Evaluation of Pain Management After Surgery When Using Nerve Blocks in the Pediatric Population (NCT06559137) | Texas Scottish Rite Hospital for Children | 2025-09-01 |
| Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral Neuropathy (NCT07082764) | Tarian Pharma | 2025-09-01 |
| Efficacy of Direct CAtheterisation of the OMbilical Vein in Emergency Through Wharton's Jelly (NCT06915467) | Hôpital NOVO | 2025-09-01 |
| Randomised EValuation of Therapies for microvAscuLar Injury in STEACS (NCT06935383) | CorFlow Therapeutics AG | 2025-09-01 |
| RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients (NCT07100184) | Peking University First Hospital | 2025-09-01 |
| Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases (NCT06877364) | S.LAB (SOLOWAYS) | 2025-09-01 |
| A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL (NCT07035379) | Zhejiang Teruisi Pharmaceutical Inc. | 2025-09-01 |
| A Study to Evaluate the Safety and Tolerability of EP0089 (NCT07030478) | Ellipses Pharma | 2025-09-01 |
| A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis (NCT07158268) | Haisco Pharmaceutical Group Co., Ltd. | 2025-09-01 |
| Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism (NCT07243561) | Dongfang People's Hospital | 2025-09-01 |
| Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets (NCT07172126) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2025-09-01 |
| Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for Cancer (NCT06999512) | Assistance Publique - Hôpitaux de Paris | 2025-09-01 |
| Ultralow Dose PET Imaging for 18F-NaF Uptake (NCT07284563) | Akiva Mintz | 2025-09-01 |
| A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT (NCT07606703) | WeiShi | 2025-09-01 |
| Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients (NCT07197164) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2025-09-01 |
| Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1 (NCT07040436) | Oncodesign Precision Medicine | 2025-09-01 |
| A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC). (NCT07101614) | Shengjing Hospital | 2025-09-01 |
| Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NCT06005649) | Juventas Cell Therapy Ltd. | 2025-09-01 |
| Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI (NCT07181499) | Betta Pharmaceuticals Co., Ltd. | 2025-09-01 |
| A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG (NCT07101367) | Ain Shams University | 2025-09-01 |
| BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients (NCT07071844) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2025-09-01 |
| Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Potentially Resectable MSI-H, dMMR Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07151209) | The First Affiliated Hospital with Nanjing Medical University | 2025-09-01 |
| The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer (NCT07160283) | The Second Affiliated Hospital of Shandong First Medical University | 2025-09-01 |
| Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations (NCT03277170) | Vanderbilt University Medical Center | 2025-09-01 |
| Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer (NCT05361915) | Sorrento Therapeutics, Inc. | 2025-09-01 |
| Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors (NCT07142837) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2025-09-01 |
| Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients (NCT07144241) | Indonesia University | 2025-09-01 |
| Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Radiotherapy (NCT07005882) | Azienda Ospedaliero-Universitaria Careggi | 2025-09-01 |
| HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma (NCT04482933) | Pediatric Brain Tumor Consortium | 2025-09-01 |
| Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer (NCT07088731) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-09-01 |
| Brachytherapy With Radiotherapy and Immunotherapy: Guided HDR Trial in Esophageal Squamous Cell Carcinoma (NCT07152678) | National Taiwan University Hospital | 2025-09-01 |
| A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of Ovarian Function Decline (NCT07535983) | Jiangxi University of Traditional Chinese Medicine | 2025-09-01 |
| Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma (NCT07159191) | Peking Union Medical College Hospital | 2025-09-01 |